PortfoliosLab logoPortfoliosLab logo
AVDL vs. QS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AVDL vs. QS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avadel Pharmaceuticals plc (AVDL) and QuantumScape Corporation (QS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


AVDL

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

QS

1D
-0.13%
1M
1.59%
YTD
-26.49%
6M
-39.21%
1Y
85.47%
3Y*
6.73%
5Y*
-24.41%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

AVDL vs. QS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
AVDL
Avadel Pharmaceuticals plc
0.42%105.04%-25.57%97.21%-11.39%20.96%-15.55%
QS
QuantumScape Corporation
-26.49%100.77%-25.32%22.57%-74.45%-73.72%757.36%

Correlation

The correlation between AVDL and QS is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Aug 17, 2020

0.21

The correlation between AVDL and QS shifts across timeframes, from 0.09 (1 year) to 0.21 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AVDL:

$2.19B

QS:

$4.68B

EPS

AVDL:

-$0.00

QS:

-$0.72

PB Ratio

AVDL:

22.31

QS:

4.22

Total Revenue (TTM)

AVDL:

$248.52M

QS:

$0.00

Gross Profit (TTM)

AVDL:

$234.76M

QS:

-$49.03M

EBITDA (TTM)

AVDL:

$10.13M

QS:

-$378.92M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AVDL vs. QS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVDL

QS
QS Risk / Return Rank: 6969
Overall Rank
QS Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
QS Sortino Ratio Rank: 7575
Sortino Ratio Rank
QS Omega Ratio Rank: 7171
Omega Ratio Rank
QS Calmar Ratio Rank: 6767
Calmar Ratio Rank
QS Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVDL vs. QS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avadel Pharmaceuticals plc (AVDL) and QuantumScape Corporation (QS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

AVDL vs. QS - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


AVDLQSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.04

Drawdowns

AVDL vs. QS - Drawdown Comparison


Loading charts...

Drawdown Indicators


AVDLQSDifference

Max Drawdown

Largest peak-to-trough decline

-97.36%

Max Drawdown (1Y)

Largest decline over 1 year

-67.68%

Max Drawdown (3Y)

Largest decline over 3 years

-73.93%

Max Drawdown (5Y)

Largest decline over 5 years

-91.45%

Current Drawdown

Current decline from peak

-94.18%

Average Drawdown

Average peak-to-trough decline

-85.55%

Ulcer Index

Depth and duration of drawdowns from previous peaks

42.96%

Volatility

AVDL vs. QS - Volatility Comparison


Loading charts...

Volatility by Period


AVDLQSDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.40%

Volatility (6M)

Calculated over the trailing 6-month period

48.57%

Volatility (1Y)

Calculated over the trailing 1-year period

103.45%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

106.01%

Dividends

AVDL vs. QS - Dividend Comparison

Neither AVDL nor QS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AVDL vs. QS - Financials Comparison

This section allows you to compare key financial metrics between Avadel Pharmaceuticals plc and QuantumScape Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M20222023202420252026
77.47M
0
(AVDL) Total Revenue
(QS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AVDL and QS have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for AVDL and QS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer